Funded Research Project
...
Science & Medicine
Development Beta2 adrenoreceptor agonist and elite athletes pharmacokinetics, physiological and pharmacogenetic ...
Search Results (9)
Funded Research Project
... Science & Medicine
Ergogenic effects of high doses beta2-agonist on aerobic capacity, muscular power and recovery in health trained men ...
Questions & Answers
News
30 September 2009
...
Salbutamol The status of salbutamol, a beta-2 agonist, will change. Therapeutic use of inhaled salbutamol will not be ...
News
2 July 2018
... List provides that Salbutamol is a prohibited beta-2 agonist under section S.3. However, as an exception, inhaled Salbutamol is ...
News
19 September 2009
... to the 2009 List. In particular, the status of salbutamol, a beta-2 agonist, will change. Salbutamol – a substance considered as specified and ...
News
19 September 2009
... to the 2009 List. In particular, the status of salbutamol, a beta-2 agonist, will change. Salbutamol – a substance considered as specified and ...
Questions & Answers
Content page
...
Development of a Samll Peptide, 2 kDa mixed standard Dr. C. GOEBEL / National Measurement Institute, ...
The Long-Term Ergogenic Effect of Long Acting Beta-2-Agonists J. DICKINSON et al. / University of Kent, UK
...